Subscribe to RSS
DOI: 10.1055/s-2003-44559
Rheological Abnormalities and Thromboembolic Complications in Heart Disease: Spontaneous Echo Contrast and Red Cell Aggregation
Publication History
Publication Date:
21 November 2003 (online)
ABSTRACT
The role of abnormal rheological changes in the pathogenesis of thromboembolism has received much attention in recent years, especially in the field of cardiology. Such changes are sometimes seen in an echocardiogram as a smokelike haze known as spontaneous echo contrast (SEC). The presence and severity of SEC correlate with dilated cardiac chambers and the incidence of thromboembolic complications. It is caused by increased red cell aggregation and increased fibrinogen levels, both of which are known risk factors for thrombosis. Although not used clinically, measurements of red cell aggregation can be made in research settings. This can provide findings that give insight into factors causing increased red cell aggregation. A small series of patients with angina pectoris was studied with the Myrenne aggregometer for red cell aggregation. The results, which show correlation between the plasma fibrinogen and triglyceride levels, are presented. As yet, there are only a few therapeutic guidelines for the correction of abnormally high fibrinogen levels in patients at risk.
KEYWORDS
Fibrinogen - red cell aggregation - spontaneous echo contrast - viscosity - thromboembolism
REFERENCES
- 1 Braunwald E. Shattuck lecture-cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med . 1997; 337 1360-1369
- 2 Koenig W, Sund M, Ernst E. et al . Association between rheology and components of lipoproteins in human blood. Results from the MONICA project. Circulation . 1992; 85 2197-2204
- 3 Chien S. Blood rheology in myocardial infarction and hypertension. Biorheology . 1986; 23 633-653
- 4 McMillan D E. The effect of diabetes on blood flow properties. Diabetes . 1983; 32 (suppl 2) 56-63
- 5 Ernst E. Haemorheological consequences of chronic cigarette smoking. J Cardiovasc Risk . 1995; 2 435-439
- 6 Lowe G D, Lee A J, Rumley A, Price J F, Fowkes F G. Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study. Br J Haematol . 1997; 96 168-173
- 7 Ernst E. Fibrinogen: its emerging role as a cardiovascular risk factor. Angiology . 1994; 45 87-93
- 8 Koenig W, Sund M, Filipiak B. et al . Plasma viscosity and the risk of coronary heart disease: results from the MONICA-Augsburg Cohort Study, 1984 to 1992. Arterioscler Thromb Vasc Biol . 1998; 18 768-772
- 9 Yang Y, Grosset D G, Li Q, Lees K R. Identification of echocardiographic "smoke" in a bench model with transcranial Doppler ultrasound. Stroke . 2000; 31 907-914
- 10 Daniel W G, Nellessen V, Schroeder E. et al . Left atrial spontaneous contrast and mitral valve disease: an indication for increased thromboembolic risk. J Am Coll Cardiol . 1998; 11 1204-1211
- 11 Fatkin D, Loupas T, Jacobs N, Feneley M T. Quantification of blood echogenicity: evaluation of a semiquantitative method of grading spontaneous echo contrast. Ultrasound Med Biol . 1995; 21 1191-1198
- 12 Ito T, Suwa M, Kobashi A. et al . Integrated backscatter assessment of left atrial spontaneous echo contrast in chronic non-valvular atrial fibrillation: relation with clinical and echocardiographic parameters. J Am Soc Echocardiogr . 2000; 13 666-673
- 13 Klein A L, Murray D, Black I W. et al . Integrated backscatter for quantification of left atrial spontaneous echo contrast. J Am Coll Cardiol . 1997; 28 222-231
- 14 Ozkan M, Kaymaz C, Kirma C. et al . Predictors of left atria thrombus and spontaneous echo contrast in rheumatic valve disease before and after mitral valve replacement. Am J Cardiol . 1998; 82 1066-1070
- 15 Shen W F, Tribouilloy C, Rida Z. et al . Clinical significance of intracavitary spontaneous echo contrast in patients with dilated cardiomyopathy. Cardiology . 2000; 87 141-146
- 16 Tsai L M, Chen J H, Tsao C J. Relation of left atrial spontaneous echo contrast with prethrombotic state in atrial fibrillation associated with systemic hypertension, idiopathic dilated cardiomyopathy, or no identifiable cause (lone). Am J Cardiol . 1998; 81 1249-1252
- 17 Costello R, Pearson A C, Fagen L. et al . Spontaneous echocardiographic contrast in the descending aorta. Am Heart J . 1990; 120 915-919
- 18 Nakagawa K, Hirai T, Shinokawa N. et al . Aortic spontaneous echocardiographic contrast and hemostatic markers in patients with non-rheumatic atrial fibrillation. Chest . 2002; 121 500-505
- 19 Asinger R W, Koehler J, Pearce L A. et al . Pathophysiologic correlates of thromboembolism in non-valvular atrial fibrillation. II. Dense spontaneous echo cardiographic contrast (The Stroke Prevention in Atrial Fibrillation (SPAF-III) Study). J Am Soc Echocardiogr . 1999; 12 1088-1096
- 20 Leung D, Black I, Cranney O, Hopkins A, Walsh W. Prognostic implications of left atrial spontaneous echo contrast in non-valvular atrial fibrilllation. J Am Coll Cardiol . 1994; 24 755-762
- 21 Chimowitz M I, DeGeorgia M A, Poole M, Hepner A, Armstrong W M. Left atrial spontaneous echo contrast is highly associated with previous stroke in patients with atrial fibrillation or mitral stenosis. Stroke . 1993; 24 1015-1019
- 22 Briley D P, Giraud G D, Beamer N B. et al . Spontaneous echo contrast and hemorheologic abnormalities in cerebral vascular disease. Stroke . 1994; 25 1564-1569
- 23 Finkelhor R S, Youssefi M E, Lamont W E, Bahler R C. Embolic risk based on aortic atherosclerotic morphologic features and aortic spontaneous echocardiographic contrast. Am Heart J . 1999; 20 979-985
- 24 Ferrari E, Vidal R, Chevallier T. et al . Atherosclerosis of the thoracic aorta and aortic debris as a marker of poor prognosis: benefit of oral anticoagulants. J Am Coll Cardiol . 1999; 33 1317-1322
- 25 Davlia-Roman V G, Murphy S F, Nickerson N J. et al . Atherosclerosis of the ascending aorta is an independent predictor of long-term neurologic events and mortality. J Am Coll Cardiol . 1999; 33 1308-1316
- 26 Steinberg E H, Madmon L, Wesolowsky H. et al . Prognostic significance of spontaneous echo contrast in the thoracic aorta: relation with accelerated clinical progression of coronary artery disease. J Am Coll Cardiol . 1997; 30 71-75
- 27 Seiji S, Katsufumi M, Yuichiro T. et al . Effect of batroxobin on spontaneous echo contrast and hemorheology in left atrial appendage in atrial fibrillation assessed by transesophageal echocardiography. Am J Cardiol . 1999; 84 816-819
- 28 Fatkin D, Loupas T, Low J. et al . Inhibition of red cell aggregation prevents spontaneous echo cardiographic contrast formation in human blood. Circulation . 1997; 96 889-896
- 29 Rastegar R, Harnick D J, Weidemann P. et al . Spontaneous echo contrast videodensity is flow related and is dependent on the relative concentrations of fibrinogen and red blood cells. Am J Cardiol . 2003; 41 603-610
- 30 Maeda N, Seike M, Kume S, Takaku T, Shiga T. Fibrinogen-induced erythrocyte aggregation: erythrocyte-binding site in the fibrinogen molecule. Biochem Biophys Acta . 1987; 904 81-91
- 31 Koenig W, Ernst E. The possible role of hemorheology in atherothrombogenesis. Atherosclerosis . 1992; 94 93-106
- 32 Kwaan H C, Levin M, Sakurai S. et al . Digital ischemia and gangrene due to red blood cell aggregation induced by acquired dysfibrinogenemia. J Vasc Surg . 1997; 26 1061-1068
- 33 Rizos E, Kostoula A, Elisaf M. et al . Effect of ciprofibrate on C-reactive protein and fibrinogen levels. Angiology . 2002; 53 273-277
- 34 Elisas M. Effects of fibrates on serum metabolic parameters. Curr Med Res Opin . 2002; 18 269-276
- 35 Ziegler O, Guerci B, Muller S. et al . Increased erythrocyte aggregation in insulin dependent diabetes mellitus and its relationship to plasma factors: a multivariate analysis. Metabolism . 1994; 43 1182-1186
- 36 Chabanel A, Horellou M H, Conard J, Samama M M. Red blood cell aggregability in patients with a history of leg vein thrombosis: influence of post-thrombotic treatment. Br J Haematol . 1994; 88 174-179
- 37 Mira Y, Vaya A, Martinez M. et al . Hemorheological alterations and hypercoagulable state in deep vein thrombosis. Clin Hemorheol Microcirc . 1998; 19 265-270
- 38 Neumann F J, Tillmanns H, Roebruck P. et al . Haemorrheological abnormalities in unstable angina pectoris: a relation independent of risk factor profile and angiographic severity. Br Heart J . 1989; 62 421-428
- 39 Neumann F J, Katus H A, Hoberg E. et al . Increased plasma viscosity and erythrocyte aggregation: indicators of an unfavourable clinical outcome in patients with unstable angina pectoris. Br Heart J . 1991; 66 425-430
- 40 Pfafferott C, Moessmer G, Ehrly A M, Bauersachs R M. Involvement of erythrocyte aggregation and erythrocyte resistance to flow in acute coronary syndromes. Clin Hemorheol Microcirc . 1999; 21 35-43
- 41 Stoltz J F, Donner M. Erythrocyte aggregation: experimental approaches and clinical implications. Int Angiol . 1987; 6 193-201
- 42 Marton Z, Kesmarky G, Vekasi J. et al . Red blood cell aggregation measurements in whole blood and in fibrinogen solutions by different methods. Clin Hemorheol Microcirc . 2001; 24 75-83
- 43 Dobbe J G, Streekstra G J, Strackee J. et al . Syllectometry: the effect of aggregometer geometry in the assessment of red blood cell shape recovery and aggregation. IEEE Trans Biomed Eng . 2003; 50 97-106
- 44 Vaya A, Martinez M, Carmena R, Aznar J. Red blood cell aggregation and primary hyperlipoproteinemia. Thromb Res . 1993; 72 119-126
- 45 Cicha I, Suzuki Y, Tateishi N, Maeda N. Enhancement of red blood cell aggregation by plasma triglycerides. Clin Hemorheol Microcirc . 2001; 24 247-255
- 46 Libby P. Inflammation in atherosclerosis. Nature . 2002; 420 868-874